Related to cancer cachexia, PDTC decreased tumor NF-κB DNA binding, which led to reduced circulating IL-6 and the attenuation of muscle mass loss in colon-26 (C26) tumor-bearing mice [18]. The gene discussed is NFKB1; the disease is cancer.